Troy– Author –
-
Market Trends
Intellia Therapeutics Bolsters Market Value with Soaring Stock Price and Improved Financials Amid Positive CRISPR Gene Editing Regulatory Progress
Fintel USA Overview Intellia Therapeutics saw its stock price climb to $12.60 per share, marking a 35.12% year-over-year increase by May 2026, boosting its market capitalization to $1.91 billion. The company also improved its net loss in... -
iPS Cells & Regenerative Medicine
UCLH Pioneering Gene Editing Therapy Successfully Lowers ‘Bad’ Cholesterol (LDL-C) with Single Dose in Encouraging Early Clinical Trial
University College London Hospitals NHS Foundation Trust UK Overview An early-stage clinical trial at University College London Hospitals (UCLH) has shown promising results where a single dose of gene editing therapy significantly lowere... -
New Technology
3D-Printed Culture System Accelerates Transplantable Gut Organoid Growth Twofold, Generating Functional Neurons Autonomously
Drug Target Review USA Overview Researchers at Cincinnati Children's Hospital have developed a 3D-printed closed culture system (CCS) that doubles the growth rate of transplantable gut organoids. This novel system produces nearly tenfold... -
iPS Cells & Regenerative Medicine
Sana Biotechnology Reports 14-Month Positive Clinical Results for Immunosuppression-Free iPSC-Derived Islet Cell Transplant in Type 1 Diabetes
Simply Wall St (via Nasdaq:SANA) USA Overview Sana Biotechnology announced continued positive clinical results from its study of iPSC-derived islet cell transplantation (UP421) for Type 1 diabetes, spanning 14 months without immunosuppre... -
iPS Cells & Regenerative Medicine
FUJIFILM Cellular Dynamics Quadruples iPSC Manufacturing Capacity with $200M New Facility in Wisconsin, Meeting Soaring Cell Therapy Demand
Manufacturing Dive USA Overview FUJIFILM Cellular Dynamics (FCDI) has inaugurated a new headquarters and iPSC development and manufacturing facility in Madison, Wisconsin, backed by a $200 million investment. This 170,000 square-foot exp... -
New Technology
CRISPR Gene Editing Evolves with Cas12a2 to Shred Sick Cell DNA, Expanding Therapeutic Horizons for Cancer and Viral Infections
Top Doctor Magazine USA Overview The CRISPR gene editing landscape is rapidly evolving in 2026, driven by the FDA approval of Cas9-based CASGEVY and the discovery of the novel Cas12a2 protein's ability to 'shred' diseased cell DNA. Unlik... -
New Technology
ASMPT Establishes Technical Advisory Council to Accelerate AI-Era Innovation in Advanced Packaging
ASMPT Singapore Overview ASMPT announced on May 28, 2026, the formation of a Technical Advisory Council (TAC) to accelerate innovation in the AI era. The TAC will provide strategic guidance on advanced packaging roadmaps, including HBM a... -
Market Trends
Digital Omnibus on AI: Provisional Compromise Reached for Streamlined EU AI Act Implementation (Part I)
Dentons UK Overview On May 27, 2026, the Permanent Representatives Committee of the Council provisionally agreed on a Digital Omnibus on AI to formally amend the EU AI Act. This omnibus aims for simpler, harmonized implementation of rule... -
Market Trends
AI Agents Reshape Entire Economy, Not Just Workforce: A Call for Robust Governance
camilleesq.substack.com USA Overview The rise of AI agents is fundamentally reshaping the entire economy, moving beyond mere workforce automation. Enterprises must rethink comprehensive governance frameworks encompassing escalation proto... -
Market Trends
AI Factory Power Draw Reshapes Grid Calculus: Direct Liquid Cooling Becomes Essential as Demand Soars
Computer Weekly UK Overview The exponential growth of AI factories is pushing data center power consumption to unprecedented levels, posing critical challenges for existing electrical grids. High-density AI processing via GPUs now mandat...